Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/677| Title: | Golimumab, a new human Anti-TNF-alpha monoclonal antibody, administered subcutaneously everv 4 weeks in methotrexate-naive patients with active rheumatoid arthritis: A randomized, double-blind, placebo-controlled, GO-BEFORE study | Authors: | Park, W. Strusberg, I. Amante, Eric Xu, W. Rahman, M. U. Hsia, E. C. Pons-Estel, B. Churchill, M. Moreland, L. W. Emery, P. Fleischmann, R. M. Durez, P. Nasi, P. |
Issue Date: | 2008 | Source: | Sep 58, (9), 2008, p. S530-S530 | Pages: | S530-S530 | Journal: | Arthritis and Rheumatism | Abstract: | 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-ProfessionalsOCT 24-29, 2008 | DOI: | 272 | Resources: | Type: | Article |
| Appears in Sites: | Sunshine Coast HHS Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.